Abeona Therapeutics Inc (NASDAQ:ABEO) has a beta value of 1.59 and has seen 1.09 million shares traded in the recent trading session. The company, currently valued at $100.68M, closed the recent trade at $3.68 per share which meant it gained $0.42 on the day or 12.88% during that session. The ABEO stock price is -144.84% off its 52-week high price of $9.01 and 23.1% above the 52-week low of $2.83. The 3-month trading volume is 519.84K shares.

Abeona Therapeutics Inc (NASDAQ:ABEO) trade information

Sporting 12.88% in the green today, the stock has traded in the red over the last five days, when the ABEO stock price touched $3.68 or saw a rise of 13.41%. Year-to-date, Abeona Therapeutics Inc shares have moved -26.55%, while the 5-day performance has seen it change -50.00%. Over the past 30 days, the shares of Abeona Therapeutics Inc (NASDAQ:ABEO) have changed -49.24%.

Abeona Therapeutics Inc (ABEO) estimates and forecasts

Figures show that Abeona Therapeutics Inc shares have underperformed across the wider relevant industry. The company’s shares have lost -4.17% over the past 6 months, with this year growth rate of 0.00%, compared to 12.90% for the industry. Revenue growth from the last financial year stood is estimated to be -85.70%.

3 analysts offering their estimates for the company have set an average revenue estimate of $170k for the current quarter. 3 have an estimated revenue figure of $170k for the next quarter concluding in Jun 2024.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 38.92% over the past 5 years.

ABEO Dividends

Abeona Therapeutics Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.